High Glucose Enhances Bupivacaine-induced Neurotoxicity via MCU-mediated Oxidative Stress in SH-SY5Y Cells
High Glucose Enhances Bupivacaine-induced Neurotoxicity via MCU-mediated Oxidative Stress in SH-SY5Y Cells
复制标题
高葡萄糖通过 MCU 介导的 SH-SY5Y 细胞氧化应激增强布比卡因诱导的神经毒性
DOI:
--
复制
发表时间:
--
影响因子:
--
通讯作者:
Shi-Yuan Xu
中科院分区:
文献类型:
--
作者:
Zhong-Jie Liu;Wei Zhao;Hong-Yi Lei;Hua-Li Xu;Lu-Ying Lai;Rui Xu;Shi-Yuan Xu
Bupivacaine, a typical local anesthetic, induces neurotoxicity via reactive oxygen species regulation of apoptosis. High glucose could enhance bupivavaine-induced neurotoxicity though regulating oxidative stress, but the mechanism of it is not clear. Mitochondrial calcium uniporter (MCU), a key channel for regulating mitochondrial Ca2+ (mCa2+) influx, is closely related to oxidative stress via disruption of mCa2+ homeostasis. Whether MCU is involved in high glucose sensitized bupivacaine-induced neurotoxicity remains unknown. In this study, human neuroblastoma (SH-SY5Y) cells were cultured with high glucose and/or bupivaciane, and the data showed that high glucose enhanced bupivacaine-induced MCU expression elevation, mCa2+ accumulation and oxidative damage. Next, Ru360, an inhibitor of MCU, was employed to pretreated SH-SY5Y cells, and the results showed that it could decrease high glucose and bupivacaine-induced mCa2+ accumulation, oxidative stress and apoptosis. Further, knock-down of MCU with a specific small interfering RNA (siRNA) in SH-SY5Y cells, we found that it also could inhibit high glucose and bupivacaine-induced mCa2+ accumulation, oxidative stress and apoptosis. We propose that down-regulation expression or activity inhibition of MCU channel might be useful for restoring the mitochondrial function and combating high glucose and bupivacaine-induced neurotoxicity. In conclusion, our study demonstrated the crucial role of MCU in high glucose-mediated enhancement of bupivacaine-induced neurotoxicity, suggesting the possible use of this channel as a target for curing bupivacaine-induced neurotoxicity in diabetic patients.